P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease ; volume:15 ; number:1 ; day:7 ; month:6 ; year:2023 ; pages:1-19 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (7.6.2023), 1-19, 12.2023

Creator: Bianchi, Carolina
Alvarez-Castelao, Beatriz
Sebastián-Serrano, Álvaro
Lauro, Caterina Di
Soria-Tobar, Lucia
Nicke, Annette
Engel, Tobias
Díaz-Hernández, Miguel

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-023-01258-x

URN: urn:nbn:de:101:1-2023091614472159677220

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bianchi, Carolina
Alvarez-Castelao, Beatriz
Sebastián-Serrano, Álvaro
Lauro, Caterina Di
Soria-Tobar, Lucia
Nicke, Annette
Engel, Tobias
Díaz-Hernández, Miguel
SpringerLink (Online service)

Other Objects (12)

Role of the ubiquitin proteasome system in Alzheimer's disease

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Hochschulschrift

Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Hochschulschrift

Ubiquitin proteasome system and myopathies

Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Role of the ubiquitin proteasome system in Alzheimer's disease

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Hochschulschrift

Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Hochschulschrift

Ubiquitin proteasome system and myopathies

Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Role of the ubiquitin proteasome system in Alzheimer's disease

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Hochschulschrift

Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Hochschulschrift

Ubiquitin proteasome system and myopathies

Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Role of the ubiquitin proteasome system in Alzheimer's disease

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ubiquitin proteasome system and myopathies

Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Role of the ubiquitin proteasome system in Alzheimer's disease

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ubiquitin proteasome system and myopathies

Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Role of the ubiquitin proteasome system in Alzheimer's disease

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ubiquitin proteasome system and myopathies

Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Related objects

Reset password